http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories View More Recent Stories
-
OptimizeRx’s Karina Castagna Named to MM+M’s 40 Under 40 List of the Medical Marketing Industry’s Brightest Young Stars
-
OptimizeRx’s Karina Castagna Named to MM+M’s 40 Under 40 List of the Medical Marketing Industry’s Brightest Young Stars
-
Optimizerx Corporation (OPRX) CEO Issues Open Letter to Shareholders Ahead of Presentation at J.P. Morgan Healthcare Conference
-
OptimizeRx CEO Issues Open Letter to Shareholders Ahead of Presentation at J.P. Morgan Healthcare Conference
-
OptimizeRx CEO Issues Open Letter to Shareholders Ahead of Presentation at J.P. Morgan Healthcare Conference
-
OptimizeRx to Participate in Upcoming Investor Conferences
-
OptimizeRx to Participate in Upcoming Investor Conferences
-
OptimizeRx Reports Third Quarter 2022 Financial Results
-
OptimizeRx Reports Third Quarter 2022 Financial Results
-
OptimizeRx and Melinta Therapeutics Present Third Annual Innovate4Outcomes(R) Healthcare Design Thinking-Inspired Event
-
OptimizeRx and Melinta Therapeutics Present Third Annual Innovate4Outcomes(R) Healthcare Design Thinking-Inspired Event
-
OptimizeRx Sets Third Quarter Fiscal 2022 Conference Call for Tuesday, November 8 at 4:30 p.m. ET
-
OptimizeRx Sets Third Quarter Fiscal 2022 Conference Call for Tuesday, November 8 at 4:30 p.m. ET
-
OptimizeRx Announces Strong Results from its use of Previously Announced AI/RWE Solution
-
OptimizeRx Announces Strong Results from its use of Previously Announced AI/RWE Solution
-
OptimizeRx Extends Exclusive Partnership with ePrescribing Leader Therapy Brands
-
OptimizeRx Extends Exclusive Partnership with ePrescribing Leader Therapy Brands
-
OptimizeRx to Participate in Upcoming September Conferences
-
OptimizeRx to Participate in Upcoming September Conferences
-
Optimizerx Corporation (OPRX) Reports Results of Physician Engagement Program
-
OptimizeRx Reports Results of Flagship Evidence-Based Physician Engagement Program
-
OptimizeRx Reports Results of Flagship Evidence-Based Physician Engagement Program
-
UPDATE – OptimizeRx Reports Second Quarter 2022 Financial Results, Innovative Platform Expansions Now Extends Reach to HCPs Across Social Media and Patients at Point-of-Dispense
-
UPDATE – OptimizeRx Reports Second Quarter 2022 Financial Results, Innovative Platform Expansions Now Extends Reach to HCPs Across Social Media and Patients at Point-of-Dispense
-
OptimizeRx Reports Second Quarter 2022 Financial Results, Innovative Platform Expansions Now Extends Reach to HCPs Across Social Media and Patients at Point-of-Dispense
-
OptimizeRx Reports Second Quarter 2022 Financial Results, Innovative Platform Expansions Now Extends Reach to HCPs Across Social Media and Patients at Point-of-Dispense
-
OptimizeRx Extends Omnichannel Reach With Cooler Screens Partnership
-
OptimizeRx Extends Omnichannel Reach With Cooler Screens Partnership
-
OptimizeRx Sets Second Quarter Fiscal 2022 Conference Call for Tuesday, August 9 at 4:30 p.m. ET
-
OptimizeRx Sets Second Quarter Fiscal 2022 Conference Call for Tuesday, August 9 at 4:30 p.m. ET
-
OptimizeRx Brings Real-World Evidence-Driven Engagement Programs to Social Media With New Exclusive Partnership
-
OptimizeRx Brings Real-World Evidence-Driven Engagement Programs to Social Media With New Exclusive Partnership
-
OptimizeRx Completes Platform Integration of TelaRep™ One-Click Prescriber Connectivity Solution
-
OptimizeRx Completes Platform Integration of TelaRep™ One-Click Prescriber Connectivity Solution
-
OptimizeRx to Participate in Upcoming June Conferences
-
OptimizeRx to Participate in Upcoming June Conferences
-
OptimizeRx’s Mike Rousselle Named One of 2022 PM360 ELITE 100
-
OptimizeRx’s Mike Rousselle Named One of 2022 PM360 ELITE 100
-
Optimizerx Corporation (OPRX) Authorizes $20 Million Share Repurchase Program
-
OptimizeRx Authorizes $20 Million Share Repurchase Program
-
OptimizeRx Authorizes $20 Million Share Repurchase Program
-
OptimizeRx to Participate in Upcoming May Conferences
-
OptimizeRx to Participate in Upcoming May Conferences
-
OptimizeRx Reports First Quarter 2022 Financial Results, Revenue Up 22%, Successfully Completes EvinceMed Acquisition
-
OptimizeRx Reports First Quarter 2022 Financial Results, Revenue Up 22%, Successfully Completes EvinceMed Acquisition
-
OptimizeRx Releases First Environmental, Social and Governance (ESG) Report
-
OptimizeRx Releases First Environmental, Social and Governance (ESG) Report
-
OptimizeRx Sets First Quarter Fiscal 2022 Conference Call for Wednesday, May 4 at 4:30 p.m. ET
-
OptimizeRx Sets First Quarter Fiscal 2022 Conference Call for Wednesday, May 4 at 4:30 p.m. ET
-
UPDATE – Surveyed Physicians Say Access Challenges Impact Their Care Plans for up to 33% of Patients

